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Inch/Pound to SI
Multiply By To obtain
cubic foot per second (ft3/s)  0.02832 cubic meter per second (m3/s)
gallon (gal)  0.003785 cubic meter (m3) 
mile (mi) 1.609 kilometer (km)
million gallons (Mgal) 3,785 cubic meter (m3)
million gallons per day (Mgal/d)  0.04381 cubic meter per second (m3/s)
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Temperature in degrees Celsius (°C) may be converted to degrees Fahrenheit (°F) as follows:
°F=(1.8×°C)+32.
Concentrations of chemical constituents in water are given either in milligrams per liter (mg/L) 
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Datums
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(NAVD 88).
Horizontal coordinate information is referenced to the North American Datum of 1983 (NAD 83).
 Acronyms
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HPLC high-performance liquid chromatography
LC50 concentration lethal to 50 percent of test organisms
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NWQL National Water Quality Laboratory
SPE solid phase extraction
USGS U.S. Geological Survey
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Abstract
A reconnaissance of pharmaceutical chemicals in 
urban streams of the Tualatin River basin was conducted in 
July 2002 in an effort to better understand the occurrence 
and distribution of such compounds, and to determine 
whether they might be useful indicators of human-related 
stream contamination. Of the 21 pharmaceutical chemicals 
and metabolites tested, only 6 (acetaminophen, caffeine, 
carbamazepine, codeine, cotinine, and sulfamethoxazole) 
were detected in filtered stream samples from 10 sites. The 
concentrations of most of the detected compounds were 
relatively low (less than 0.05 microgram per liter). The most 
frequently detected compounds were cotinine (a nicotine 
metabolite, 8 of 10 samples) and caffeine (a stimulant, 7 
of 10 samples). More compounds were detected in urban 
stream samples than in samples from forested or agricultural 
drainages.
Filtered water samples also were collected from four 
locations within an advanced wastewater treatment facility 
to quantify the relative amounts of these chemicals in a 
municipal waste stream and to determine the degree to which 
those chemicals are removed by treatment processes. Fifteen 
pharmaceutical chemicals or metabolites were detected in 
wastewater treatment facility influent, with concentrations 
far exceeding those measured in streams. Only five of those 
compounds, however, were detected in the treated effluent 
(carbamazepine, cotinine, ibuprofen, metformin, and 
sulfamethoxazole) and most of those were at concentrations 
less than 0.2 microgram per liter.
The target pharmaceutical chemicals and metabolites 
showed limited potential for use as tracers of specific types 
of human-related contamination in Tualatin River basin 
streams because of widespread sources (caffeine, for example) 
or extremely low concentrations. Caffeine and cotinine are 
likely to be good indicators of sources that can occur in 
urban areas, such as sewage spills or leaks or the widespread 
use and careless disposal of tobacco products and caffeine-
containing beverages. Neither compound, however, is likely 
to be a good tracer for a specific source unless that source 
is large. The presence of 1,7-dimethylxanthine (a caffeine 
metabolite) concurrently with caffeine might indicate the 
presence of untreated wastewater; in contrast, the absence of 
the metabolite might help rule out that source. Acetaminophen 
might make a good tracer for untreated wastewater because 
of its common usage, high concentration in raw wastewater, 
and effective removal via treatment. Carbamazepine and 
sulfamethoxazole have the potential to be good indicators of 
treated wastewater because of their incomplete removal in 
treatment facilities. Some of these pharmaceutical chemicals, 
either singly or in combination, might prove useful as tracers 
of contamination after further study.
Introduction
Background
Modern pharmacologic research since the middle of the 
19th century has resulted in the development or discovery 
of numerous drugs for the treatment of disease and the 
relief of ailments. The numbers and types of these drugs, 
or pharmaceutical chemicals, and the amounts used, have 
increased greatly in the last several decades, to the point where 
thousands of drugs are used today. Many are in common 
or daily use in the world’s developed countries (Kaufman 
and others, 2002). Increased use can lead to increased 
concentrations in waste streams and the potential for release 
of ever larger loads of these compounds to the environment. 
Prior to the last 10 years, few studies had been performed to 
determine the sources, transport, and fate of such compounds. 
An array of published studies now are available showing that 
pharmaceutical chemicals and their metabolites are present 
in streams at a wide range of concentrations, particularly 
downstream of human population centers (Halling-Sørensen 
and others, 1998; Daughton and Ternes, 1999). Researchers 
have investigated the occurrence of pharmaceuticals in 
surface waters (Buser and others, 1998; Kolpin and others, 
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2002; Calamari and others, 2003; Löffler and others, 2005) 
and groundwater (Seiler and others, 1999; Hinkle and 
others, 2005; Barnes and others, 2008), the presence of such 
compounds in and their removal from wastewater (Ternes, 
1998; Ternes and others, 2004; Jones and others, 2005), and 
the ecological effects of these compounds (Wilson and others, 
2003; Gagné and others, 2006; Kim and others, 2007).
Despite these research efforts, few data exist to quantify 
the occurrence, concentration, and likely ecological effects 
of pharmaceutical chemicals in surface waters. A national 
reconnaissance was carried out in 1999–2000 by the U.S. 
Geological Survey (USGS) to assess the presence and 
concentrations of a suite of pharmaceuticals and other 
compounds in 139 streams across the United States (Kolpin 
and others, 2002). That study provides a good framework 
and baseline for developing a better understanding of the 
occurrence of pharmaceuticals and their metabolites in the 
Nation’s streams, but was not designed to determine the 
occurrence and effects of these compounds on a local scale; 
for example, only three water samples from Oregon were 
analyzed as part of that study. Given a growing and aging 
population with increased reliance on pharmaceuticals 
for the treatment of medical conditions, increased use of 
pharmaceuticals in agriculture, and greater public interest 
in the quality of drinking water and the health of aquatic 
species, the need to learn more about the occurrence and 
concentrations of pharmaceutical chemicals in Oregon’s 
streams is becoming increasingly important.
Some important source pathways of pharmaceutical 
chemicals, such as wastewater treatment facilities (WWTFs, 
which receive waste from hospitals, households, and 
municipal industries), have been identified in previous studies 
and need to be considered and assessed locally. Ternes 
(1998) was one of the first to document the presence of 
pharmaceuticals in raw and treated wastewater, using samples 
from selected WWTFs in Germany. Most modern WWTFs 
were not designed specifically to remove pharmaceutical 
chemicals from the waste stream. Many such chemicals 
are removed fairly efficiently through standard wastewater 
treatment, but others are not. Even if a large fraction of a 
pharmaceutical is removed through treatment, the remaining 
load still may constitute a large source to the receiving 
water body. Similar conclusions were reached in other 
studies in which higher concentrations of pharmaceuticals 
were measured downstream of WWTFs or population 
centers (Buerge and others, 2003; Kolpin and others, 2004; 
Glassmeyer and others, 2005; Gagné and others, 2006; Han 
and others, 2006; Karthikeyan and Meyer, 2006; Wilkison and 
others, 2006; Guo and Krasner, 2009). Research by Bedner 
and MacCrehan (2006) suggested that the chlorination process 
used in some WWTFs might transform acetaminophen, 
a common analgesic and one of the most widely used 
pharmaceutical chemicals, into a more harmful form. It is not 
just the parent pharmaceuticals, therefore, but their metabolites 
and degradates that must be studied to better understand the 
full effect of pharmaceuticals in the environment.
The potential for ecological effects caused by the 
presence of pharmaceuticals and their metabolites in aquatic 
systems is poorly understood at this time (2009). Because 
these compounds inherently affect physiological processes, it 
is likely that a measurable and potentially harmful ecological 
effect could occur at some concentration, but more research 
is necessary to define the ecological risks. Gagné and others 
(2006), for example, detected a wide range of pharmaceuticals 
in municipal treatment facility effluent and determined 
that such compounds have the potential to produce a toxic 
response in rainbow trout. Kim and others (2007) examined 
the toxicity of four widely used pharmaceuticals and six 
sulfonamide antibiotics and determined that several might 
have acutely toxic effects at concentrations greater than 
1 mg/L and that some potential ecological risk is present at 
lower concentrations. Han and others (2006) assessed the 
ecotoxicological effect of a handful of pharmaceuticals on 
a common plankton species, determined that toxic effects 
can occur at sufficiently high concentrations, and found that 
although typical pharmaceutical concentrations downstream 
of certain WWTFs did not result in a significant risk, the 
potential for significant risk did exist. The ecological effects 
of pharmaceuticals in the environment is a subject with many 
unexplored topics such as synergistic effects, the risks of 
chronic and multiple-year exposure to trace concentrations, 
and the risks resulting from pharmaceutical metabolites and 
degradates.
In addition to WWTF sources, pharmaceuticals and 
other biological and chemical contaminants can enter 
surface waters through accidental or illicit dumping, poorly 
managed or failing on-site or septic systems, storm-sewer/
sanitary-sewer cross connections, and unmanaged pet and 
animal wastes, among other sources. Proactive management 
and protection of aquatic resources would greatly benefit 
from the development of one or more definitive methods of 
identifying and tracking these separate sources. A wide variety 
of techniques and tracers are being developed in response 
to this need. Genetic techniques, for example, are becoming 
increasingly useful in identifying the sources of bacteria 
detected in streams (Stoeckel and others, 2004). Chemicals 
such as caffeine historically have proven useful as markers of 
human-related contaminant sources (Buerge and others, 2003), 
but that use may be diminishing because of the widespread 
consumption and careless disposal of caffeinated beverages. 
Other studies have found that, in addition to caffeine, certain 
anionic surfactants and fluorescent whitening agents (the 
“optical brighteners” in some laundry detergents) are good 
indicators associated with fecal coliform contamination 
(Sankararamakrishnan and Guo, 2005). Standley and others 
(2000) found that certain fragrance compounds, in conjunction 
with caffeine, can be used as tracers of human-related 
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contaminant sources. The identification of a suite of chemical 
markers that is unique to human-related sources of stream 
pollution would prove invaluable to investigations of 
contaminant fate and transport as well as the management of 
water resources. 
Pharmaceutical chemicals represent a compound class 
with great potential for use as tracers of specific sources of 
anthropogenic pollution. For use as a tracer of human-related 
contamination, a candidate compound should have few or 
no natural sources, no normal means of entering the stream 
of interest, a well-defined usage pattern, a sufficiently long 
lifetime to allow detection in the environment, and a reliable 
and accurate means of detecting and quantifying its presence 
in water, sediment, or tissue samples. Many pharmaceutical 
chemicals fit this general profile, although it is unclear which 
candidate pharmaceuticals might make the best tracers for 
sources of human-related stream contamination.
Study Area
The Tualatin River basin in northwest Oregon includes 
the western edge of Portland (Oregon’s largest city) and 
Portland’s western suburbs and outlying communities. 
In 2002, the basin was home to a rapidly growing human 
population of about 500,000 (U.S. Census Bureau, 2006). 
The great majority of those people live within a designated 
urban growth boundary which contains the cities of Portland, 
Beaverton, Tigard, Tualatin, Hillsboro, and Forest Grove, to 
name just a few (fig. 1). The cities are located primarily on the 
valley floor and are gathered mainly toward the middle and 
eastern edge of the basin. From its headwaters in the forested 
Coast Range mountains to the west, the Tualatin River 
meanders east through agricultural areas on the valley bottom 
before skirting the southern edge of the urban area and joining 
the Willamette River south (upstream) of Portland.
Figure 1. Tualatin River basin, Oregon.
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In a basin that is characterized by cool, wet winters 
and warm, dry summers, the Tualatin River typically has its 
highest streamflow of several thousand cubic feet per second 
in the winter during large eastward-moving Pacific storms, 
and its lowest flow of less than 200 ft3/s during late summer. 
Summer streamflow is reduced by irrigation withdrawals, 
but augmented by upstream reservoir releases and treated 
effluent from two large WWTFs. The Rock Creek and Durham 
WWTFs, operated by Clean Water Services, process an annual 
average of 60 Mgal/d of wastewater for more than 480,000 
customers. During the low-flow summer period, the WWTFs 
add about 70 ft3/s (45 Mgal/d), or as much as 35 percent, 
to the flow of the Tualatin River (Bonn, 2008a). The Rock 
Creek and Durham WWTFs are advanced tertiary treatment 
facilities that use activated sludge treatment and chemical 
precipitation to remove nutrients and organic matter, followed 
by chlorination, filtration, and dechlorination for disinfection. 
The Rock Creek WWTF discharges to the Tualatin River just 
south of Hillsboro, and the Durham WWTF discharges to the 
Tualatin River near the mouth of Fanno Creek near Durham 
(fig. 1).
Tualatin River tributaries are readily grouped by 
characteristics that mirror the predominant land use within 
their drainages. Fanno, Rock, and Beaverton Creeks are the 
major streams draining urban areas of the Tualatin River 
basin. Fanno Creek has a well-established and completely 
(100 percent) urbanized drainage. The presence of a large 
human population, with a relatively dense urban development 
structure, sanitary and storm-sewer network, and extensive 
impervious areas, results in a diverse array of potential sources 
of stream pollution that are different from those in agricultural 
or forested drainages. In contrast to Fanno Creek, the Gales 
Creek drainage is predominantly forested (70 percent forest, 
27 percent agricultural) and the Dairy Creek drainage has a 
large percentage of agricultural land use (50 percent) with 
most of the rest being forested (41 percent; data from 2001 
National Land Cover Database, see Homer and others, 2007).
Purpose and Scope
The occurrence of pharmaceuticals and their metabolites 
in natural waters can cause adverse effects on ecosystem 
health. Pharmaceuticals are designed to have physiological 
effects, and some disrupt the endocrine system or are toxic to 
aquatic species (Halling-Sørensen and others, 1998; Daughton 
and Ternes, 1999). Prior to this study, few data existed to 
quantify the occurrence or concentration of pharmaceutical 
chemicals in streams of the Tualatin River basin. The primary 
purpose of this study is to eliminate this data gap as a step 
toward determining whether this class of compounds affects 
ecosystem health in the Tualatin River basin. Until a range 
of contaminant concentrations is measured, the magnitude of 
the ecological effect cannot be assessed and the appropriate 
resource management actions cannot be designed.
Of the thousands of pharmaceutical chemicals being 
manufactured and used, only a small subset was included in 
this study. The 21 candidate compounds were selected based 
upon (a) their estimated national use, an important factor 
in determining which compounds are likely to be detected 
in stream water, and (b) laboratory recovery performance 
and compound-specific detection levels achievable in newly 
developed analytical detection methods. The target analyte list 
includes a wide range of chemical classes and pharmaceutical 
uses, from analgesics and antibiotics to anticonvulsants, 
antihistamines, and stimulants (table 1). The target analytes 
include several pharmaceutical metabolites; in some cases, the 
metabolite is likely to be measured in higher concentrations 
than the parent compound. Though the metabolites are 
important, the terminology in this report has been simplified 
such that the 18 pharmaceutical chemicals and 3 metabolites 
on the target analyte list are commonly grouped together and 
called “pharmaceuticals.”
For many reasons, including the lack of previous data and 
the high cost of analyzing water samples for pharmaceutical 
chemicals, this study was by necessity a reconnaissance. The 
sampling strategy paralleled the objectives of the study, which 
were to:
• Measure the occurrence and concentration of a 
target set of pharmaceutical chemicals in streams 
of the Tualatin River basin, with a focus on highly 
urbanized drainages;
• Estimate the removal rates of pharmaceutical 
chemicals within an advanced WWTF; and
• Assess the utility of pharmaceutical chemicals as 
tracers of human-related contamination of streams.
Most stream samples were collected from six sites in the 
highly urbanized Fanno Creek subbasin of the Tualatin 
River basin; two other samples were collected from nearby 
agricultural and forested drainages for comparison. These sites 
could be affected by many types of source pathways, but none 
have treated wastewater sources (other than septic) upstream. 
Additional samples were collected within, upstream, and 
downstream of a large advanced WWTF that discharges to 
the Tualatin River. The emphasis on an urban stream and the 
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WWTF reflects the information needs of a growing population 
and those of Clean Water Services, which is the primary 
stormwater- and wastewater-management utility for the urban 
areas of Washington County in the Tualatin River basin.
This study was exploratory in nature and limited in its 
scope. Stream samples were collected just once from each 
location in late July 2002 during a period of low streamflow 
preceded by at least 2 weeks of dry weather. Results, therefore, 
are not indicative of stormwater runoff sources but should 
capture dry-weather sources such as permitted discharges, 
leaking sewer lines, illicit dumping, and storm-sewer/sanitary-
sewer cross-connection problems, if present. The presence 
or relative importance of stormwater-related sources was not 
assessed. Sampling during low streamflow is advantageous 
because the sources are not diluted by rainfall runoff. 
Similarly, the dry-weather sampling strategy minimized the 
amount of stormwater delivered to the WWTF and maximized 
the volumetric fraction of treated effluent in the Tualatin 
River downstream of the facility’s outfall, thus making an 
assessment of the facility’s downstream effects more apparent 
and straightforward to quantify. These results, however, may 
not be representative of the presence of pharmaceuticals in 
the Tualatin River because the sampling design was biased 
towards sample collection conditions that increased the 
likelihood of detectable pharmaceutical concentrations. 
The purpose of this report is to document the results of 
this study, draw conclusions related to the study’s objectives, 
and postulate future directions for similar research activities.
Table 1. Pharmaceutical chemicals and metabolites included in this study.
[The list of common names is far from complete and is included only for utilitarian purposes. Similarly, the list of uses may be incomplete. This information 
was obtained from the Merck Index (1989) and from common on-line information sources. CAS, Chemical Abstracts Service. CAS Registry Numbers® is a 
Registered Trademark of the American Chemical Society. CAS recommends the verification of the CASRNs through CAS Client ServicesSM. 
–, not applicable]
Compound
CAS  
registry No.
Common name Intended use
Acetaminophen 103-90-2 Tylenol Analgesic
Albuterol (Salbutamol) 18559-94-9 Ventolin, Airomir MDI Bronchodilator (for asthma)
Caffeine 58-08-2 No-Doz Stimulant
Carbamazepine 298-46-4 Epitol, Tegretol Anticonvulsant; antimanic (mood stabilizer)
Cimetidine 51481-61-9 Tagamet Antiulcerative (acid reducer)
Codeine 76-57-3 Robitussin AC Opioid narcotic; cough suppressant
Cotinine 486-56-6 – Metabolite of nicotine
Dehydronifedipine 67035-22-7 – Metabolite and photodegradation product of nifedipine (arterial 
dilator; antihypertensive)
Diltiazem 42399-41-7 Cardizem Antianginal; antiarrhythmic; antihypertensive
1,7-Dimethylxanthine 611-59-6 – Metabolite of caffeine
Diphenhydramine 58-73-1 Benadryl, Allerdryl Antihistamine; sedative
Fluoxetine 54910-89-3 Prozac Antidepressant
Gemfibrozil 25812-30-0 Lopid Antihyperlipidemic (lipid regulating agent)
Ibuprofen 15687-27-1 Advil, Motrin, Nuprin Analgesic; anti-inflammatory
Metformin 657-24-9 Glucophage Antidiabetic (antihyperglycemic)
Miconazole 22916-47-8 Micatin, Monistat Topical antifungal
Ranitidine 66357-35-5 Zantac Antiulcerative (acid reducer)
Sulfamethoxazole 723-46-6 Bactrim, Septra (component) Antibiotic; antibacterial
Thiabendazole 148-79-8 Arbotect, Mertect Systemic antifungal; livestock antiparasitic
Trimethoprim 738-70-5 Bactrim, Septra (component) Antibiotic; antibacterial
Warfarin 81-81-2 Coumadin Anticoagulant
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Methodology
Sample Sites
Samples for pharmaceutical chemical analysis were 
collected from eight stream sites (Tualatin River tributaries), 
two Tualatin River sites upstream and downstream of 
discharge from an advanced WWTF, and four locations within 
that treatment facility (table 2, fig. 2). The stream sites were 
chosen to represent a range of urban, agricultural, and forested 
land uses in the Tualatin River basin, with an emphasis on the 
urban areas. Six of the stream sites (sites 1–6) are located in 
the highly urbanized Fanno Creek drainage, while site 7 on 
Gales Creek represents more of a forested drainage and site 8 
on Dairy Creek has substantial agricultural land use upstream. 
Sites 1 and 2 in the upper reaches of Fanno Creek, site 5 on 
Summer Creek, and site 6 on the unnamed creek represent 
small drainages in largely residential urban areas. The Summer 
Creek drainage may have a larger fraction of residences with 
on-site septic systems rather than service from the sanitary 
sewer system. The remaining two sites farther downstream 
on Fanno Creek (sites 3 and 4) include increasing amounts 
of commercial and industrial land use. In addition to point-
source discharges, few of which are present in the Fanno 
Creek drainage, pharmaceutical chemicals may be present in 
urban streams as a result of accidental discharge, intentional 
dumping of waste (from a recreational vehicle, for example), 
sanitary-sewer/storm-sewer cross connections, leaking sewer 
lines, and failing septic systems, to name a few. Caffeine may 
be present in streams as a result of people discarding coffee-
cup residue on the street, which then can be washed to a storm 
drain and from there into the nearest creek.
Samples were collected from four locations within Clean 
Water Service’s Durham WWTF to assess the concentrations 
of pharmaceuticals that are delivered to the facility and their 
removal from the waste stream. The Durham WWTF is an 
advanced treatment facility that uses state-of-the-art treatment 
technology and attains a higher level of phosphorus removal, 
for example, than 98 percent of WWTFs in the United States 
(Clean Water Services, 2002). The facility uses screening, 
primary settling, enhanced biological treatment, tertiary 
chemical treatment, chlorination, sand-bed filtration, aeration, 
and dechlorination processes (fig. 3). Although the treatment 
is designed primarily to remove solids, oxygen demand, 
ammonia, and phosphorus, the effluent is near drinking-water 
Table 2. Samples collected for pharmaceutical chemical analysis in the Tualatin River basin, Oregon, 2002.
[Sampling site No.: Location of sampling sites are shown in figure 2. WWTF, wastewater treatment facility; –, not applicable]
Sampling 
site No.
Site type Site name
Site  
identification  
No.
Drainage 
area  
(mi2)
Sample 
type
Date Time
1 Urban Fanno Creek at 56th Avenue 14206900 2.4 regular 7-30-2002 9:00
duplicate 7-30-2002 9:00
2 Urban Fanno Creek near Allen Boulevard 14206925 8.9 regular 7-30-2002 9:40
duplicate 7-30-2002 9:40
3 Urban Fanno Creek at Highway 99W 14206942 24.8 regular 7-30-2002 9:15
4 Urban Fanno Creek at Durham City Park 452348122454701 31.7 regular 7-30-2002 10:10
duplicate 7-30-2002 10:20
5 Urban Summer Creek at Fowler Middle School 452559122472401 6.2 regular 7-29-2002 9:40
duplicate 7-29-2002 9:40
6 Urban Unnamed Creek at Walnut Street in Tigard 452547122465900 0.8 regular 7-29-2002 10:10
7 Forested Gales Creek at Old Highway 47 14204530 74.7 regular 7-25-2002 10:20
8 Agricultural Dairy Creek at Highway 8 14206200 229 regular 7-25-2002 11:25
9 Integrator Tualatin River at Cook Park 14206800 655 regular 7-31-2002 10:00
10 Integrator Tualatin River at Boones Ferry Road 14206960 692 regular 7-31-2002 11:00
11 WWTF Durham WWTF – headworks 452359122454501 – regular 7-31-2002 11:00
Durham WWTF – pre-filtration 452359122454502 – regular 7-31-2002 13:35
Durham WWTF – post-filtration 452359122454503 – regular 7-31-2002 10:20
Durham WWTF – effluent 452359122454504 – regular 7-31-2002 10:30
duplicate 7-31-2002 10:40
– Quality assurance Blank (organic blank water) – – blank 7-31-2002 16:00
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Figure 2. Location of sites sampled in this study.
quality and typically dilutes many of the regulated chemicals 
in the Tualatin River’s receiving water. The Durham WWTF 
serves a customer base of more than 200,000 people and 
has a dry-weather discharge of about 25 ft3/s (16 Mgal/d). 
On July 31, 2002, the day of sample collection, the mean 
facility discharge was 24 ft3/s, but ranged as high as 40 ft3/s 
and as low as about 12 ft3/s. Samples of influent (at the 
headworks) and effluent were collected. Additional samples 
were collected before and after the filtration step, which is 
downstream of primary, secondary, and tertiary treatment and 
after chlorination, but prior to final aeration and dechlorination 
(fig. 3). Samples were collected without attempting to 
follow a single parcel of influent through the WWTF; the 
6-hour residence time and multiple recirculation pathways 
within the facility make such a sampling strategy difficult 
to perform. Results from these samples, therefore, are only 
strictly comparable if the influent waste stream was somewhat 
invariant in its loading of pharmaceutical chemicals.
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To assess the instream effect of WWTF effluent, samples 
were collected from the Tualatin River 0.6 mi upstream 
(site 9, Cook Park) and 0.6 mi downstream (site 10, Boones 
Ferry Road) of the Durham WWTF outfall on the same day 
and at about the same time that samples were collected from 
the WWTF. On July 31, 2002, streamflow in the Tualatin 
River was about 171 ft3/s upstream of the outfall and 198 ft3/s 
downstream of the outfall. These streamflows were estimated 
based on measured streamflows at several streamflow-gaging 
stations upstream and downstream of the WWTF outfall.
Sampling and Processing Methods
Water samples from stream and river sites were collected 
using standard USGS protocols. Where stream size and 
depth allowed, the depth- and width-integrating equal-width 
increment (EWI) water-sampling technique was used. In the 
EWI method, a sample is collected by lowering and raising a 
sampler through the water column at a constant specified rate, 
repeating the process at the center of a set of equally spaced 
locations in the stream cross-section, and compositing the 
collected waters (Edwards and Glysson, 1999). EWI samples 
were collected using either a DH-81 hand-held sampler 
for wadeable streams or a D-77 sampler for non-wadeable 
streams with a 3-L Teflon® sample bottle and a Teflon® cap/
nozzle assembly. The unnamed creek at Walnut Street (site 6, 
fig. 2) was not deep or large enough to use the EWI method; 
instead, a grab sample was collected using the protocols and 
considerations for nonstandard sampling documented by 
Shelton (1994). Samples were placed on ice for transport back 
to the USGS Oregon Water Science Center laboratory for later 
filtration. 
Samples of water were collected from four different 
locations at the Durham WWTF. Because of safety, access, 
and structural considerations at the facility, nonstandard 
sampling techniques were used, typically resulting in grab 
samples of the source water. Samples were placed on ice 
before transporting them to the laboratory for later filtration.
Special protocols were followed to prevent contamination 
of the water samples. The sampling crew was careful to 
avoid contact with or consumption of any products or 
materials that contain the target analytes in this study. For 
example, the potential introduction of trace amounts of 
caffeine into collected samples was minimized through the 
crew’s abstention from caffeine-containing beverages (such 
as coffee), and protecting the samples from contact with 
human exhalations. These types of sample-handling and 
contamination-avoidance procedures are described by Lewis 
and Zaugg (2003) in the USGS National Field Manual.
Standard USGS procedures for handling and filtering 
samples containing organic compounds were followed prior 
to the shipment of samples to the USGS National Water 
Quality Laboratory (NWQL) in Denver, Colorado. Samples 
were filtered using a stainless steel or aluminum 142-mm or 
293-mm diameter plate-filter assembly with a 0.7-micron pore 
size glass-fiber filter. A valveless-piston variable-speed pump 
with Teflon® tubing was used, and sufficient filtrate from each 
sample was collected to fill two 1-L amber glass bottles that 
had been cleaned and baked at 350°C. Standard protocols 
for sample processing are documented in section 5.2.2 of the 
USGS National Field Manual (Wilde and others, 2004). All 
filtered samples were shipped on ice to the USGS NWQL for 
analysis.
The use of filtered water samples in this study, a 
requirement of the laboratory analysis method, means that 
the results reflect only the dissolved fraction of the target 
compounds’ total mass in the collected water samples. 
Although many of the target compounds are fairly water 
soluble (some even are ionized under neutral pH conditions, 
which makes them extremely water soluble), a fraction of 
their mass in a whole-water sample may be associated with 
suspended particulate material. As a result, the measured 
concentrations from a filtered sample may be lower than 
the concentration that would be measured in a whole-water 
sample.
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Laboratory Analysis
Filtered water samples were analyzed for a suite of 18 
pharmaceuticals and 3 metabolites by the Methods Research 
and Development group at the USGS NWQL using a 
relatively new analytical method (Cahill and others, 2004; 
Furlong and others, 2008). In that method, the target analytes 
and an added performance surrogate first were removed from 
filtered 1-L water samples by passing the water through a 
solid-phase extraction (SPE) cartridge. The analytes then 
were eluted from the SPE cartridge using small volumes of 
methanol and acidified methanol, concentrated to near dryness, 
reconstituted into formate buffer with an internal standard, 
and filtered. The concentrates were analyzed using high-
performance liquid chromatography interfaced with a mass 
spectrometer using electrospray ionization operated in the 
positive-ion mode (HPLC–ESI–MS). Selected-ion monitoring 
MS was used to improve sensitivity and specificity. For more 
details on the specific materials, extraction procedures, and 
instrument conditions, see Cahill and others (2004) or Furlong 
and others (2008).
The analytical method used in this study was still under 
development at the time of sample collection and analysis. For 
that reason, the lists of target analytes in the published method 
papers (Cahill and others, 2004; Furlong and others, 2008) 
are slightly different from the target analytes in this study. In 
the most recent version of the analytical method documented 
by Furlong and others (2008), 11 pharmaceuticals and 
3 metabolites were analyzed, all of which were included in this 
study. Seven additional compounds (cimetidine, fluoxetine, 
gemfibrozil, ibuprofen, metformin, miconazole, and ranitidine) 
were included in this study, six of which also were included 
by Cahill and others (2004). Of the 21 compounds analyzed 
in this study, only miconazole was omitted by both of the 
published method papers. Method detection limits and spike 
recovery information for all of the target analytes are included 
later in this report with the results and the quality assurance 
data. Because this method incorporates a mass spectrometer 
as a detector, the qualitative identification of a compound 
can be verified, if not reliably quantified, at concentrations 
less than the method detection limit (Childress and others, 
1999; Bonn, 2008b); such detections are reported as estimated 
concentrations only.
Quality Assurance
The quality assurance program for this study included 
field duplicate samples and equipment blanks, and laboratory 
blanks and spikes. The field equipment blank was composed 
of certified organic blank water (EM Science, Universal 
Blank Water, lot #42044: purity verification data available 
upon request) that was filtered and handled using the same 
procedures as those used for the stream samples. Duplicate 
water samples were collected at five sites (table 2) to test the 
reproducibility of field and laboratory procedures. In addition, 
as part of the laboratory method, each set of analyzed samples 
included a laboratory blank sample and a spiked blank sample.
Spike recovery results from this study, and from 67 
additional laboratory spike samples analyzed during method 
development in 2002, demonstrated that the analytical method 
produced mixed results for this set of 21 target analytes 
(table 3). For 11 of the analytes, the spike recovery was 
consistently greater than 60 percent, and results were deemed 
reliable enough to report without qualification. Mean spike 
recoveries for eight other analytes were between 20 and 
60 percent; this less reliable recovery requires that quantified 
concentrations for these compounds be reported only as 
estimates. Spike recoveries for the final two compounds on 
the target analyte list, metformin and miconazole, were poor 
(6 percent or less); any detections of these compounds were 
reported without quantification.
Blank samples from the field and the laboratory were, 
with one exception, devoid of the target analytes. A low-level 
concentration of fluoxetine (0.0039 µg/L) was detected in the 
equipment blank sample, reducing the reliability of any low-
level detections for that compound; fluoxetine results already 
were qualified as estimates based on low spike recovery 
results. No other target compounds were detected in the blank 
samples. Table 3 lists the spike recovery data, blank results, 
and interpreted reporting guidance for each compound (report 
without qualification, report as estimate, etc.).
Duplicate sample results showed good agreement, 
providing assurance that the detection frequency and the 
quantified concentrations were reliable. For the five duplicate 
water samples included in this study, a target analyte was 
detected in 15 instances in which a paired duplicate result 
also was available. In 12 of the 15 instances, the analyte 
was detected in both samples; in only 3 instances was a 
compound detected in only 1 of the paired samples. As 
might be expected, the percent relative difference in the 
quantified concentrations of paired results was higher for the 
lowest concentrations. For concentrations less than 0.1 µg/L, 
the relative percent difference was about 19 percent (10 
comparisons), and that value decreased to about 5 percent 
for concentrations greater than 0.1 µg/L (2 comparisons). 
Concentrations closer to the detection limit, therefore, are 
expected to be more uncertain than those that are well above 
the detection limit.
Matrix interferences can cause quality assurance issues 
that are difficult to quantify. The influent sample from the 
Durham WWTF, although filtered, had a complex organic 
chemical signal that could not completely be cleaned up 
or avoided during the sample extraction and concentration 
process. These interfering chemicals were incompletely 
separated from the target analytes during the chromatographic 
procedure, thus decreasing signal-to-noise ratios, increasing 
detection limits, and decreasing the certainty of compound 
identification and quantitation. Although results from the 
Durham influent sample were double-checked by re-running 
the analysis, all those results have a greater uncertainty due to 
matrix interferences.
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Pharmaceutical Chemical Detections 
and Concentrations
Reconnaissance Results
This reconnaissance of pharmaceutical chemicals in 
streams of the Tualatin River basin was conducted in late 
July 2002. Stream samples were collected between July 25 and 
July 30, and the Tualatin River and the Durham WWTF were 
sampled on July 31 (table 2). Late July in western Oregon 
typically is warm and dry, and streams in the Tualatin River 
basin at that time are composed predominantly of groundwater 
baseflow. In the case of the Tualatin River, additional flow 
comes from upstream reservoir releases and the treated 
effluent from two advanced WWTFs. Prior to sample 
collection, no measurable rain had occurred since July 8, 
although a trace was recorded on July 26 (USGS data: see site 
452359122454500, for example, at http://or.water.usgs.gov/
grapher/).
A wide variety of sources can deliver pharmaceutical 
chemicals to streams. During dry weather, such sources might 
include failing septic or other on-site waste-treatment systems, 
leaking sewer lines, permitted and accidental discharges, 
illicit and unpermitted dumping, sanitary-sewer/storm-sewer 
cross connections, and unmanaged or poorly managed pet and 
livestock wastes. Stormwater sources are not included in this 
reconnaissance, which is important to remember because the 
storm-sewer system in the study area generally discharges 
to the stream network rather than to a treatment facility. The 
dry-weather sampling increased the chances of detecting 
Table 3. Results of quality control analyses for pharmaceutical chemicals included in this study. 
[The 2002 spike recovery data were from laboratory data collected throughout fiscal year 2002 — before, during, and after this study. %, percent;  
Std. Dev., standard deviation of spike recovery results; μg/L, microgram per liter] 
Compound
Clean 
blanks?
Range of  
spike recovery  
(this study, %)
Mean (and Std. Dev.)  
of 67 set spikes  
(2002 results, %)
Comment
Acetaminophen yes 69–88 72 (15) Results reported without qualification.
Albuterol (Salbutamol) yes 70–90 74 (10) Results reported without qualification.
Caffeine yes 75–104 85 (16) Results reported without qualification.
Carbamazepine yes 68–84 71 (11) Results reported without qualification.
Cimetidine yes 33–43 30 (9.3) Reduced probability of low-level detection. Reported 
concentrations are estimates.
Codeine yes 66–91 94 (25) Results reported without qualification.
Cotinine yes 68–92 74 (12) Results reported without qualification.
Dehydronifedipine yes 71–100 77 (15) Results reported without qualification.
Diltiazem yes 48–61 47 (11) Reported concentrations are estimates.
1,7-Dimethylxanthine yes 96–127 105 (36) Results reported without qualification.
Diphenhydramine yes 51–62 53 (11) Reported concentrations are estimates.
Fluoxetine no 19–43 27 (14) Blank problems (up to 0.004 μg/L). Reduced probability of 
low-level detection.  Reported concentrations are estimates.
Gemfibrozil yes 59–87 30 (21) Reported concentrations are estimates.
Ibuprofen yes 24–121 51 (24) Variable spike recovery. Imprecise quantitation. Reported 
concentrations are estimates.
Metformin yes 0–2 4 (4.8) Very low probability of low-level detection. No concentrations 
reported, only detections.
Miconazole yes 1–22 6 (7.1) Very low probability of low-level detection. No concentrations 
reported, only detections.
Ranitidine yes 45–56 41 (13) Reported concentrations are estimates.
Sulfamethoxazole yes 64–90 51 (18) Reported concentrations are estimates.
Thiabendazole yes 73–94 75 (16) Results reported without qualification.
Trimethoprim yes 67–88 70 (12) Results reported without qualification.
Warfarin yes 59–80 63 (13) Results reported without qualification.
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pharmaceuticals from dry-weather sources because dilution 
by rainfall was avoided. The absence of rain also meant that 
the Durham WWTF was handling its normal load of domestic 
and other municipal/industrial sewage; therefore, the effect 
of WWTF effluent on the Tualatin River was representative 
of summer low-flow conditions and the relative proportion of 
treated effluent in the river was somewhat maximized, thus 
making its source load easier to detect.
Of the 21 target analytes included in this study, six were 
not detected in any sample, and only six were detected in 
any of the stream or river samples (tables 4 and 5). Stream 
sample detections included cotinine, caffeine, acetaminophen, 
carbamazepine, codeine, and sulfamethoxazole, in decreasing 
order of detection frequency. Sulfamethoxazole and 
carbamazepine primarily were found in the Tualatin River 
rather than in the smaller drainages, and the main source 
of the two compounds in the river probably was treated 
WWTF effluent; none of the smaller creek sites have WWTF 
discharges upstream of their sampling locations. Fifteen of 
the 21 target analytes were detected in WWTF influent; in 
contrast, only five were detected in treated effluent.
The most commonly detected compound was cotinine, 
which was found in every urban stream sample, both samples 
from the Tualatin River, and all WWTF samples. Cotinine is 
a metabolite of nicotine, which is an ingredient of tobacco-
containing products; therefore, cotinine is delivered to 
municipal WWTFs on a consistent basis through the sanitary 
sewer. Given the widespread outdoor use of nicotine-
containing products, it is not surprising that cotinine was 
detected in all urban stream samples. Similarly, caffeine was 
the second most-detected compound, and it also was found 
in all urban stream samples. Caffeine is present in high 
concentrations in coffee-based beverages, soft drinks, and 
energy drinks, and the propensity of many people to discard 
the remains of those beverages on streets and parking lots 
may account for the prevalence of caffeine in urban stream 
samples. Wash-off from streets and parking lots typically 
is conveyed to the nearest stream through the storm-sewer 
system with minimal opportunity for degradation, and little 
of the storm-sewer network has been retrofitted to deliver 
stormwater to wetlands or other naturalized treatment 
facilities. Note that if wash-off from streets and parking lots 
was instrumental in delivering these compounds to streams, 
then the dry-weather sampling performed in this study 
may have been affected by previous stormwater delivery 
processes. Despite the universal detection of caffeine in urban 
stream samples in this study, none of those samples included 
detections of 1,7-dimethylxanthine, which is the primary 
metabolite of caffeine (Guerreiro and others, 2008) and is 
present in high concentrations in untreated wastewater. The 
absence of this metabolite in urban stream samples reinforces 
the suggestion that the source of caffeine to these urban 
streams does not include processing through the human body, 
and therefore does not come from treatment, septic, or sewer-
related sources.
Most of the target analytes in this study (15 of 21) 
were not detected in stream or river samples. Only three 
compounds (acetaminophen, caffeine, cotinine) were detected 
in urban stream samples, and the great majority of those 
detections were at concentrations less than 0.04 µg/L with 
half of those detections at less than 0.01 µg/L (table 4). For 
perspective, 0.01 µg/L is nearly identical to half a drop of 
the pure compound diluted into a 660,000-gal Olympic-sized 
swimming pool, and 660,000 gal is the total amount of water 
used if you were to flush a modern 1.6-gal water-saving toilet 
25 times a day for the next 45 years. With only a couple of 
exceptions, the detected concentrations were less than about 4 
to 5 times the analytical method detection limit. One sample 
did show a substantially higher concentration of caffeine 
(0.314 µg/L) than any other stream sample, perhaps indicating 
a nearby source. Only two compounds (acetaminophen, 
carbamazepine) were detected in Gales Creek and only one 
(caffeine) was detected in Dairy Creek, and all three were 
estimated at concentrations less than their method detection 
limits. Even the Tualatin River samples, which were affected 
by one or more upstream WWTF sources, showed only four 
compound detections (carbamazepine, codeine, cotinine, 
sulfamethoxazole), and two (codeine and sulfamethoxazole) of 
the four were estimated at concentrations less than the method 
detection limit. In general, this reconnaissance of the target 
pharmaceutical chemicals indicates that these compounds 
either are not present in Tualatin River basin streams or are 
present only at trace concentrations that are many orders 
of magnitude below their usage or pharmacological dosing 
levels. For many of these compounds, it is not yet known 
whether these trace concentrations have ecological effects.
The effects of upstream land use were not clearly defined 
with the limited number of samples collected in this study. 
The samples collected from the Gales (forested) and Dairy 
(agricultural) Creek sites, however, certainly had fewer of 
the target compounds detected and all such detections were 
estimated at concentrations less than their method detection 
limits. The target analyte list, however, did not include the 
most commonly used antibiotics used in veterinary medicine, 
which might partially explain the paucity of detections in the 
agricultural drainage. The biggest difference between these 
two samples and the urban stream samples was the consistent 
presence of caffeine and cotinine in the urban samples. 
Caffeine and cotinine, therefore, may be good indicators for 
sources associated with urban areas. The Gales and Dairy 
Creek sites have little upstream urban land use (2 and 7 
percent, respectively).
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Comparison to Other Data
Samples were collected by the USGS in 1999–2000 from 
139 streams across the United States, including several from 
Oregon streams (Barnes and others, 2002; Kolpin and others, 
2002), in a reconnaissance of pharmaceutical chemicals, 
hormones, and organic wastewater contaminants. Results 
from that investigation provide a useful comparison to this 
study. The list of pharmaceutical compounds included in the 
national reconnaissance was similar to the target analyte list 
in this study, largely because the same analytical method 
was used. Seventeen of the target compounds in this study 
were included in the national reconnaissance, and of the 
six compounds that were detected in stream samples in this 
study, only carbamazepine was not included in the national 
reconnaissance. Results for the five remaining detected 
compounds are compared to results from the national study 
in figure 4. The concentrations detected in this study are 
similar to and consistent with those from the national study. 
Maximum concentrations detected in this study, however, 
were at least an order of magnitude less than the maxima 
from the national study. This could be due to chance, given 
that the national study included about 10 times more samples, 
but it also may indicate that samples from the Tualatin River 
basin have fewer or weaker upstream sources of the target 
pharmaceuticals.
In both the national reconnaissance and this study, a 
sample was collected from the Tualatin River at Boones 
Ferry Road (site 10). The sample in the national study was 
collected on June 3, 2000, was preceded by only 3 days of 
dry weather, and showed detections for caffeine, codeine, 
1,7-dimethylxanthine, sulfamethoxazole, and trimethoprim. 
In this study, only codeine, sulfamethoxazole, and cotinine 
were detected (carbamazepine also was detected but was not 
included in the national study). Concentrations of the detected 
compounds in the two samples were of similar ranges, but 
neither consistently higher nor lower. Because both samples 
were collected during the low-flow summer period, upstream 
sources of these compounds were likely to be similar. 
Although storm-related sources may have been more prevalent 
in the sample from the national study, such sources were 
not specifically assessed in this study and their importance 
remains unknown. In any case, the results indicate that the low 
concentrations and few detections obtained for the Tualatin 
River sample in this study are not an anomaly.
Table 5. Detection frequency for pharmaceutical chemicals analyzed in this study. 
[Grey shading highlights combinations with no detections. WWTF, wastewater treatment facility]
Compound
Detection frequency (detections/number of samples)
All streams Urban streams Forested streams Agricultural streams Tualatin River WWTF
Acetaminophen 3/10 2/6 1/1 0/1 0/2 1/4
Albuterol (Salbutamol) 0/10 0/6 0/1 0/1 0/2 0/4
Caffeine 7/10 6/6 0/1 1/1 0/2 1/4
Carbamazepine 3/10 0/6 1/1 0/1 2/2 4/4
Cimetidine 0/10 0/6 0/1 0/1 0/2 1/4
Codeine 2/10 0/6 0/1 0/1 2/2 1/4
Cotinine 8/10 6/6 0/1 0/1 2/2 4/4
Dehydronifedipine 0/10 0/6 0/1 0/1 0/2 0/4
Diltiazem 0/10 0/6 0/1 0/1 0/2 2/4
1,7-Dimethylxanthine 0/10 0/6 0/1 0/1 0/2 1/4
Diphenhydramine 0/10 0/6 0/1 0/1 0/2 1/4
Fluoxetine 0/10 0/6 0/1 0/1 0/2 1/4
Gemfibrozil 0/10 0/6 0/1 0/1 0/2 0/4
Ibuprofen 0/10 0/6 0/1 0/1 0/2 2/4
Metformin 0/10 0/6 0/1 0/1 0/2 2/4
Miconazole 0/10 0/6 0/1 0/1 0/2 0/4
Ranitidine 0/10 0/6 0/1 0/1 0/2 1/4
Sulfamethoxazole 2/10 0/6 0/1 0/1 2/2 3/4
Thiabendazole 0/10 0/6 0/1 0/1 0/2 0/4
Trimethoprim 0/10 0/6 0/1 0/1 0/2 1/4
Warfarin 0/10 0/6 0/1 0/1 0/2 0/4
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Depending on the chemical properties of the target 
pharmaceuticals, these compounds might be more likely to be 
found in stream sediment rather than in the overlying water. 
Nilsen and others (2007) determined that sediment samples 
collected from streams in the lower Columbia River drainage 
network do contain trace concentrations of pharmaceutical 
chemicals. Four of the samples in that study were collected 
from either Fanno Creek near its confluence with the 
Tualatin River, or from the Tualatin River near the outfall 
of the Durham WWTF. Those samples included detections 
of caffeine, diphenhydramine, thiabendazole, diltiazem, 
miconazole, trimethoprim, dehydronifedipine, carbamazepine, 
cotinine, fluoxetine, and codeine, in descending order of 
detected concentration or frequency. Detected concentrations 
ranged from about 1 to about 70 ng/g of sediment. In contrast, 
only four of these compounds (caffeine, carbamazepine, 
cotinine, and codeine) were detected in filtered water samples 
from the same general sampling sites in this study. 
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Figure 4. Concentrations of pharmaceuticals and metabolites detected in stream and river samples in this study and instream 
concentrations from a 1999–2000 national study (Barnes and others, 2002). One site in the national study was from the Tualatin 
River at Boones Ferry Road, a site that also was sampled in this study. The concentration distributions from the national study 
are truncated at their reporting level, though confirmed detections below the reporting level are shown at their estimated 
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The aqueous concentrations of pharmaceutical 
compounds in this study cannot be compared directly to the 
sediment-associated concentrations detected by Nilsen and 
others (2007) because the samples were not collected at the 
same time or from exactly the same location. Even if collected 
concurrently from the same site, water samples would reflect 
conditions at that time, whereas sediment samples (collected at 
1–2 cm depth by Nilsen) represent time-integrated processes 
of accumulation and degradation. Further research is necessary 
to quantify the concentrations and proportions of these 
compounds in various media (water, sediment, fish tissue), but 
it is instructive to make rough comparisons using available 
data, in the interest of learning more about instream processes. 
For example, caffeine was detected in water and in sediments 
from Fanno Creek near its mouth. Aqueous concentrations 
from this study were roughly 0.02 µg/L (identical to  
0.02 ng/mL or 0.02 ng/g), and the sediment-associated 
concentration measured by Nilsen and others (2007) was about 
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57 ng/g. Given the fact that caffeine is not charged under 
neutral pH conditions, and that its octanol-water partition 
coefficient (Kow) is about 1.0, nearly equal concentrations 
of caffeine in water and in the organic component of 
the sediments would be expected. These data, however, 
indicate that the phases are not in equilibrium—the aqueous 
concentration is lower than expected based on the sediment-
associated concentration. Perhaps the caffeine in the aqueous 
phase is readily degraded or the upstream sources are 
sufficiently variable that the phases are never in equilibrium. 
In contrast to caffeine, many pharmaceutical chemicals (such 
as ibuprofen) have acid-base properties that greatly increase 
their aqueous solubility under environmentally relevant 
pH conditions and decrease the relevance of hydrophobic 
partitioning to sedimentary organic matter (Wells, 2006). 
When considering the fate of pharmaceutical chemicals in 
the environment, it is critical to know how their chemical 
properties affect their aqueous solubility, bioaccumulation, 
bio- and photo-degradation, and partitioning to sediments and 
the atmosphere. More research and sampling is needed to fully 
understand the presence and fate of pharmaceutical chemicals 
in Tualatin River basin streams, sediments, and biota.
Effects of Wastewater Treatment
The highest concentrations of any target analyte in this 
study were found in the influent sample from the Durham 
WWTF. Five compounds were detected at concentrations 
greater than 1 µg/L. Caffeine and acetaminophen had the 
highest concentrations (30 and 29 µg/L, respectively), 
followed closely by 1,7-dimethylxanthine (24 µg/L), 
ibuprofen (7.6 µg/L), and cotinine (1.5 µg/L) (table 4). The 
presence of these particular pharmaceuticals and metabolites 
in high concentrations in wastewater is entirely consistent with 
typical usage rates. Although caffeine is an active ingredient 
in some medications, the adult per capita consumption rate of 
caffeine through beverages has been estimated as 320 mg/d 
in the United States; no other pharmaceutical in this study has 
such a high consumption rate (Wilkison and others, 2006). 
Furthermore, a national usage survey performed in 1998–99 
reported that acetaminophen and ibuprofen were the two 
most commonly used pharmaceuticals, with caffeine in ninth 
place, not including the consumption of caffeine in beverages 
(Kaufman and others, 2002). Despite the high concentrations 
of these compounds in WWTF influent, 3 of these 5, and 
10 of the 15 target compounds detected in WWTF influent, 
were not detected in samples of the treated WWTF effluent. 
Only carbamazepine, cotinine, ibuprofen, metformin, and 
sulfamethoxazole were detected in the effluent (table 4).
The influent and effluent detection data from this study, 
although from a limited number of samples, can be used to 
calculate an apparent removal rate of these compounds due 
to treatment processes occurring in the Durham WWTF, 
assuming that the compound concentrations detected in 
influent and effluent are typical. Because WWTFs are efficient 
at removing particulate material, and because this study 
analyzed only filtered water samples, these calculated removal 
rates may be biased low, depending on the water solubility of 
the target compound. For those compounds that were detected 
in the influent but not in the effluent, a lower limit on the 
apparent removal rate can be estimated based on the analytical 
method detection limit for each compound. For those that 
were detected in influent and effluent, a percent removal 
can be computed directly (table 6). Most of the compounds 
detected in the influent were removed with fairly high 
efficiency (> 90 percent). Ibuprofen and sulfamethoxazole 
were mostly but incompletely removed (> 75 percent), but 
only a small fraction (< 20 percent) of the antiepileptic drug 
carbamazepine was removed. Results for ibuprofen were 
somewhat inconsistent because it was detected in only one of 
two duplicate effluent samples. Results from samples collected 
before and after filtration in the WWTF showed that filtration 
was not responsible for the removal of these compounds from 
the waste stream; most of the removal occurred prior to that 
treatment step.
Table 6. Apparent removal rates of pharmaceutical compounds 
from wastewater by the Durham WWTF. 
[Results are shown only for the 14 target compounds detected and quantified 
in Durham WWTF influent. If a compound was not detected in WWTF 
effluent, the method detection limit was used to compute the apparent removal 
rate; such instances are denoted with an asterisk (*).  >, greater than;  
%, percent; WWTF, wastewater treatment facility]
Compound
Apparent 
removal
 Compound
Apparent 
removal
Acetaminophen > 99%*  1,7-Dimethylxanthine > 99%*
Caffeine > 99%* Diphenhydramine > 98%*
Carbamazepine 18% Fluoxetine > 82%*
Cimetidine > 97%* Ibuprofen > 77%
Codeine > 98%* Ranitidine > 98%*
Cotinine 97% Sulfamethoxazole 84%
Diltiazem > 92%* Trimethoprim > 94%*
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Many other studies have evaluated the removal rates of 
pharmaceuticals from wastewater. Ternes (1998) investigated 
the occurrence and removal of a suite of pharmaceuticals in 
German WWTFs, and determined that more than 60 percent 
of the pharmaceutical residues were removed. Many were 
not detected in the treated effluent, some such as ibuprofen 
(90 percent removal) were mostly removed through 
treatment, and others such as carbamazepine (7 percent 
removal) were only partially removed. Those results for 
ibuprofen and carbamazepine mirror the results from this 
study. A 2004 survey of pharmaceuticals in South Korean 
WWTFs by Han and others (2006) showed similar results 
for ibuprofen (78 percent removal), but quite different results 
for carbamazepine (91 percent removal) and acetaminophen 
(9 percent removal). The type of treatment (primary versus 
secondary, trickling filter versus activated sludge, with 
or without nitrification and/or denitrification processes, 
chlorination versus UV disinfection) and the details of the 
treatment processes (residence time, etc.) can have an effect 
on the removal of pharmaceuticals from wastewater (Jones 
and others, 2005; Phillips and others, 2005).
Samples from the Tualatin River upstream and 
downstream of the Durham WWTF outfall provide an 
independent means of assessing the effect of WWTF 
effluent on the river. Three of the five target analytes 
detected in WWTF effluent (carbamazepine, cotinine, and 
sulfamethoxazole) also were detected in the Tualatin River 
upstream and downstream of the Durham outfall. For those 
compounds, a mass balance of sorts can be performed. 
Because the approximate flow in the river upstream of the 
outfall (171 ft3/s), the flow rate of the effluent (about 24 ft3/s), 
and the flow in Fanno Creek (< 5 ft3/s) are known, an 
expected downstream concentration can be computed. In the 
case of carbamazepine, the in-river concentration increased 
from 0.038 µg/L upstream to 0.046 µg/L downstream 
(table 4), which is consistent with an expected downstream 
concentration of about 0.052 µg/L based on a mass balance. 
Similarly consistent results were obtained for cotinine, 
with upstream and downstream measured concentrations 
of 0.0098 and 0.014 µg/L, versus an expected downstream 
concentration of 0.016 µg/L based on a mass balance. In-river 
concentrations of sulfamethoxazole were essentially the same 
upstream and downstream of the Durham WWTF outfall 
(0.015 and 0.014 µg/L), whereas the mass balance produced 
an expected downstream concentration of 0.017 µg/L; 
given the uncertainty involved in the analyses, these three 
concentrations are essentially identical. Ibuprofen was not 
detected in the river samples, perhaps providing evidence to 
question the detection of ibuprofen in treated effluent, where 
only one of two duplicate effluent samples showed a detection 
(1.77 µg/L). If ibuprofen had been present in treated effluent 
at a concentration of 1.77 µg/L, then the in-river downstream 
concentration should have been easily detected at an estimated 
concentration of 0.2 µg/L, which is 10 times higher than the 
method detection limit. The laboratory analytical method used 
in this study was not, perhaps, the best method for quantifying 
ibuprofen concentrations; new analytical methods for 
ibuprofen and other acidic pharmaceutical chemicals are under 
development.
In-river concentrations of carbamazepine and cotinine 
upstream of the Durham WWTF outfall (Tualatin River at 
Cook Park, site 9) can be shown to be consistent with the 
presence of a large WWTF source upstream of that location. 
The Rock Creek WWTF discharges treated effluent to the 
Tualatin River about 28 mi upstream of Cook Park, and the 
travel time from the WWTF outfall to Cook Park was about 
6–8 days under the flow conditions that occurred in late 
July 2002. For all of the carbamazepine in the Tualatin River 
at Cook Park to have come from the Rock Creek WWTF, 
the effluent flow rate from that facility would have to be 
about 41 ft3/s, assuming its carbamazepine concentration was 
identical to that in Durham WWTF effluent and assuming no 
instream degradation during the travel time to Cook Park. The 
measured Rock Creek WWTF effluent flow rate for that time 
period was about 39 ft3/s. A similar calculation for cotinine 
only required that the Rock Creek WWTF effluent flow rate 
be at least 34 ft3/s, and sources of cotinine from other urban 
streams such as Rock Creek certainly were present. It is 
likely, therefore, that concentrations of carbamazepine and 
cotinine in the Tualatin River upstream of the Durham WWTF 
outfall primarily are from the Rock Creek WWTF. Similar 
calculations for sulfamethoxazole reveal that the Rock Creek 
WWTF probably is an important source of that compound to 
the river, but it may not be the only source upstream of Cook 
Park unless the concentration of sulfamethoxazole in Rock 
Creek WWTF effluent was higher than the concentration in 
Durham WWTF effluent.
The ecotoxicological risk of carbamazepine to selected 
aquatic species has been studied by several research 
groups. Han and others (2006) studied the effects of several 
pharmaceutical chemicals on daphnia magna, a common 
planktonic crustacean, and determined that the typical 
concentrations of pharmaceuticals downstream of South 
Korean WWTFs were low enough that no appreciable 
risk existed. Indeed, the LC50 (concentration lethal to 
50 percent of test organisms) for carbamazepine cited in 
that research is 111 mg/L, about 2,400 times higher than 
the concentration detected in Tualatin River samples. A 
safety factor of 1,000 typically is applied in their analyses, 
indicating that the concentrations found in this study may 
not pose a significant ecological risk to this particular test 
organism. Related research by Kim and others (2007) 
showed little risk by carbamazepine to daphnia magna or 
to a test fish species. They reported potential concern for 
effects from acetaminophen and sulfamethoxazole, but the 
exposure concentrations they used were more than 60 times 
higher than those found in Tualatin River samples; the lower 
concentrations measured in this study would push the risk 
below their hazard thresholds. Another study by Oetken and 
others (2005) investigated the effect of carbamazepine on 
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an oligochaete, a midge, and a freshwater snail species. The 
aquatic testing in that study indicated that the concentrations 
found in the Tualatin River would not pose a threat to these 
species. In general, insufficient data exist to completely 
ascertain the ecological risk of pharmaceutical chemicals to 
species that reside in the Tualatin River and its tributaries, 
but limited data for compounds such as carbamazepine, 
acetaminophen, and sulfamethoxazole suggest that the acute 
ecological risk under normal low-flow conditions is low. 
Although pharmaceutical chemical concentrations normally 
might be low in the Tualatin River, accidental releases or spills 
of sewage could greatly increase their instream concentrations 
and their associated ecological risk. In addition, low-level 
chronic exposure to those pharmaceutical chemicals that can 
act as endocrine disrupters could lead to a harmful ecological 
effect, but such an effect cannot yet be assessed.
Use of Pharmaceutical Chemicals as Tracers of 
Human-Related Stream Contamination
Although the analysis of samples for pharmaceutical 
chemicals is expensive, the cost might be justified if one or 
more of the compounds proved to be a good tracer for specific 
sources of stream contamination. Results from previous 
studies indicate that caffeine and selected pharmaceuticals 
may be useful as confirmatory evidence of contamination, 
if not sufficient as primary evidence (Seiler and others, 
1999; Verstraeten and others, 2005). Caffeine also has been 
proposed as an ideal tracer for certain types of sewage-related 
contamination of streams because of its high concentration 
in human waste and the absence of substantive natural 
sources (Ferreira, 2005; Wu and others, 2008). Unless the 
sewage-related stream contamination is large, however, the 
use of caffeine as a source indicator is limited because trace 
concentrations of caffeine appear to be common in urban 
streams. Indeed, caffeine was universally present in urban 
stream samples in this study at concentrations generally 
greater than 0.01 µg/L. That concentration is fairly easy 
to achieve with only a few spills of coffee, although other 
sources also may be present. For example, if coffee has a 
caffeine concentration of 350 mg/L (Seiler and others, 1999), 
and a stream such as Fanno Creek has a flow of about 4 ft3/s, 
then a caffeine concentration of 0.01 µg/L in the stream 
represents a spill of only 1 ounce of coffee residue that is 
completely mixed into the stream every 2.5 hours. A 1-ounce 
coffee spill need only mix into 5 minutes worth of the stream’s 
flow to achieve the highest concentration measured in this 
study (0.314 µg/L), a dilution level that is certainly possible, 
although perhaps unlikely. To use caffeine as an effective 
tracer for a sewer leak, the leak would have to be large enough 
to produce caffeine concentrations higher than a few tenths of 
a microgram per liter. At that level, a different indicator such 
as coliform bacteria or an optical brightener might prove to be 
less ambiguous, faster to analyze, and more cost-effective.
Although caffeine might be used only as a general tracer 
for mixed sources of human-related stream contamination, 
or as a tracer for large sewer leaks, compounds like 
acetaminophen, carbamazepine, and sulfamethoxazole 
might be useful as tracers under some circumstances. These 
compounds (a common analgesic, an antiepileptic drug, and 
an antibiotic, respectively) are unlikely to be detected in 
streams unless a human-related or veterinary source is present. 
Such a source could be a leaking sewer line, a failing septic 
system, illicit or unpermitted dumping, or a storm-sewer/
sanitary-sewer cross connection. In the presence of one of 
these sources, the instream concentration of acetaminophen 
ought to be easily measurable, given its high concentration 
in municipal wastewater (29 μg/L; table 4). Instream 
concentrations of carbamazepine and sulfamethoxazole might 
be lower than that of acetaminophen, at least in untreated 
sewage, but these compounds are not completely removed 
by wastewater treatment, so they could be used as tracers of 
either raw or treated wastewater sources. Carbamazepine has 
been proposed previously as a marker for human wastewater 
(Clara and others, 2004). In separate research, Glassmeyer and 
others (2005) suggested that pharmaceutical chemicals such 
as carbamazepine, diphenhydramine, and caffeine might be 
good indicators of the presence of human wastewater. Guo and 
Krasner (2009) recently determined that carbamazepine and 
primidone may be used as indicators of upstream wastewater 
sources. The data derived from this Tualatin River basin 
reconnaissance show that several of these pharmaceutical 
compounds might make good tracers for human-related 
contamination of streams under some circumstances, but 
that additional research and sampling are needed to further 
evaluate their potential use as tracers.
Summary and Conclusions
A reconnaissance of pharmaceutical chemicals and 
metabolites in urban streams and an advanced wastewater 
treatment facility was conducted on the west side of the 
Portland, Oregon, metropolitan area during low-flow 
conditions in July of 2002. Filtered water samples were 
analyzed for 21 target analytes using a solid-phase-
extraction procedure followed by high-performance liquid 
chromatography and mass spectrometric detection. Only 6 
of the target compounds were detected in the 10 stream or 
river sites that were sampled. Among the urban stream sites, 
the only compounds detected were cotinine (a metabolite 
of nicotine), caffeine, and acetaminophen. The highest 
concentration in any stream or river sample was for caffeine in 
Fanno Creek at 0.314 µg/L, but the next highest concentration 
was almost an order of magnitude lower at 0.046 µg/L 
for carbamazepine in the Tualatin River downstream of 
two wastewater treatment facility outfalls. All compound 
concentrations measured in this study were consistent with 
the range of concentrations reported in a 1999–2000 national 
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survey of pharmaceutical compounds in United States 
streams by USGS, but maximum concentrations in this study 
were about an order of magnitude or more lower. Although 
this study is only a reconnaissance for the occurrence and 
concentrations of selected pharmaceuticals in Tualatin River 
basin streams, it appears that few pharmaceuticals are present 
in these streams, and when present, their concentrations are 
low. Furthermore, limited literature data suggest that the 
dry-weather concentrations of some compounds detected in 
this study are not high enough to be of ecological concern. 
Insufficient information is available, however, to fully assess 
the true ecological risk, including those associated with storm-
related conditions and potential spills or accidental releases.
Fifteen pharmaceuticals and metabolites were detected 
in untreated municipal wastewater, but most were efficiently 
removed through treatment. Only five compounds were 
detected in treated effluent from the Durham treatment 
facility (carbamazepine, cotinine, ibuprofen, metformin, 
and sulfamethoxazole), and two of those (ibuprofen and 
metformin) were detected in only one of two duplicate 
effluent samples. Of these compounds, only carbamazepine 
is somewhat resistant to removal through wastewater 
treatment, with an apparent removal of only 18 percent; all 
other detected compounds had at least a 77 percent estimated 
removal rate. The apparent removal rates determined in 
this study are consistent with some previous studies of 
pharmaceutical chemicals in wastewater treatment facilities, 
although published studies differ widely on the removal rates 
of carbamazepine and acetaminophen. Results indicate that 
wastewater treatment facilities are the primary sources of the 
low concentrations of carbamazepine and cotinine measured in 
Tualatin River samples. Published research indicates that the 
dry-weather concentrations of carbamazepine, acetaminophen, 
and sulfamethoxazole found in Tualatin River basin samples 
are unlikely to be toxic to the several plankton and freshwater 
snail species used as test organisms.
Several of the pharmaceutical chemicals and metabolites 
included in this study, either singly or in combination, 
show some potential to be useful tracers of human-related 
contamination of streams. Although caffeine and cotinine 
appear to be good indicators of a wide variety of sources that 
can occur in urban areas, they are not good indicators of any 
single sewage-related source, for example, unless that source 
is large enough to overcome the smaller background sources. 
If present along with caffeine, 1,7-dimethylxanthine (a 
caffeine metabolite) might indicate the presence of untreated 
wastewater; in contrast, the absence of the metabolite might 
help rule out a wastewater source, treated or untreated, 
because caffeine and 1,7-dimethylxanthine are effectively 
removed via wastewater treatment. Acetaminophen, 
carbamazepine, and sulfamethoxazole show some potential 
as tracers for specific types of contamination, either because 
of high concentrations in raw wastewater (acetaminophen) 
or because of incomplete removal by wastewater treatment 
(carbamazepine, sulfamethoxazole). Ibuprofen also has a high 
concentration in raw wastewater and potentially incomplete 
removal in wastewater treatment, but is not an ideal candidate 
because the analytical test method used in this study gave 
imprecise results for this compound. Additional research 
is needed to fully determine the potential value of these or 
other pharmaceutical chemicals and metabolites as tracers for 
stream contamination. Other potential tracers such as optical 
brighteners, fragrance compounds, and surfactants also merit 
further consideration.
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